HORSHAM, PA — STRATA Skin Sciences, Inc. (Nasdaq: SSKN) said it filed a Form 25 with the U.S. Securities and Exchange Commission on Thursday, February 19, 2026, to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, confirming that trading of its shares was suspended on the Nasdaq Capital Market at the opening of business the same day.
The company said it expects to file a Form 15 with the SEC on or about March 2, 2026, to terminate registration of its common stock under Section 12(g) of the Exchange Act and suspend its reporting obligations under Sections 13(a) and 15(d), a process commonly referred to as “going dark.”
STRATA previously disclosed in a Form 8-K filed February 11, 2026, that it expected delisting and going dark would reduce the effort and cost associated with maintaining compliance as an Exchange Act reporting company and generate savings in general and administrative expenses.
Chief Executive Officer and Vice Chairman Dr. Dolev Rafaeli said the decision was not related to financial instability or weakness in the company’s business.
“The pathway taken by the Company was not due to any financial instability of the Company or any weakening in the Company’s business,” Rafaeli said, adding that the company ended fiscal year 2025 with approximately $8 million in cash.
Rafaeli said the company has engaged its lender regarding potential changes to loan terms to reflect its profile as a private company and that management is confident in a favorable outcome of those discussions.
He also said that without the need to focus on Nasdaq listing requirements, management would be better positioned to concentrate on anticipated growth tied to expanded market opportunities for its XTRAC® excimer laser and TheraclearX® systems following changes in CPT codes.
Rafaeli acknowledged that the company’s common stock would likely become less liquid as a result of going dark and that shareholders may face difficulty selling shares. He said the board weighed those factors against the current and potential future costs of remaining a listed company.
STRATA Skin Sciences develops and markets medical technology products for the treatment of dermatologic conditions.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.